PMID: 9525435Apr 3, 1998Paper

Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association
J P LalezariH S Jaffe

Abstract

To assess the effect of intravenous cidofovir on delaying progression of previously treated, relapsing cytomegalovirus (CMV) retinitis, we conducted a randomized, controlled comparison of two maintenance dose levels of cidofovir. One hundred and fifty patients with AIDS and CMV retinitis that had progressed or was persistently active despite treatment with ganciclovir, foscarnet, or both were randomized to receive induction cidofovir, 5 mg/kg once weekly for 2 weeks, then maintenance therapy with either 5 mg/kg or 3 mg/kg once every other week. Concomitant probenecid and intravenous hydration were administered with each cidofovir dose. Retinitis progression was assessed in the first 100 patients by bilateral, full-field retinal photographs read at a central reading center by an ophthalmologist masked to treatment assignment. Incidence of side effects, changes in visual acuity, and mortality were also assessed. Median time to retinitis progression as assessed by retinal photography was not reached (95% confidence interval [CI], 115 days-upper limit not reached) in the 5-mg/kg group, and was 49 days (95% CI, 35-52 days) in the 3-mg/kg group (p = .0006). Dose-dependent asymptomatic proteinuria (39%) and serum creatinine elevation ...Continue Reading

References

Jan 23, 1992·The New England Journal of Medicine·UNKNOWN Studies of Ocular Complications of AIDS Research Group, UNKNOWN AIDS Clinical Trials Group
Jan 1, 1989·Archives of Ophthalmology·D A JabsJ G Bartlett
Aug 26, 1989·Lancet·D M KornhauserP S Lietman
Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·K K BironD J Nelson
Aug 1, 1983·Ophthalmology·G N HollandR Y Foos
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·K V Clemons, D A Stevens
Dec 23, 1993·The New England Journal of Medicine·D R HooverR A Kaslow
Sep 23, 1993·The New England Journal of Medicine·R SnoeckC Sadzot-Delvaux

❮ Previous
Next ❯

Citations

May 23, 2003·Current Infectious Disease Reports·William Lawrence Drew
Mar 5, 2004·Survey of Ophthalmology·Tamara R Vrabec
Jun 5, 2003·Pharmacology & Therapeutics·Santo LandolfoDavid Lembo
Mar 31, 2000·Pharmacology & Therapeutics·J Zemlicka
Jul 20, 2002·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·D PillayUNKNOWN Public Health Laboratory Service Advisory Committee on Virology
Feb 19, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W G Nichols, M Boeckh
Dec 12, 2001·HIV Medicine·D Salmon-Ceron
Sep 5, 1996·The New England Journal of Medicine·C S Crumpacker
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Berenguer, J Mallolas
Apr 21, 2005·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Constance A BensonUNKNOWN Infectious Diseases Society of America
Aug 4, 2005·Retina·Daniel E GoldbergWilliam R Freeman
Jun 26, 2008·Pediatric Dermatology·Caitriona CusackAlan D Irvine
May 8, 2002·CNS Drugs·Matthias MaschkeHans-Christoph Diener
Mar 1, 2006·Expert Opinion on Drug Safety·Christina M Wyatt, Paul E Klotman
Jun 18, 2003·The American Journal of the Medical Sciences·Mark A Perazella
Dec 24, 2002·The American Journal of the Medical Sciences·Steven Coca, Mark A Perazella
Dec 17, 2009·Advances in Chronic Kidney Disease·Jennifer Jao, Christina M Wyatt
Dec 25, 2007·Dental Clinics of North America·Mark A LermanNathaniel S Treister
Jun 10, 2008·Pediatric Transplantation·Carlos E ArayaVikas R Dharnidharka
Feb 28, 2006·Pediatric Transplantation·Carlos E ArayaVikas R Dharnidharka
Nov 27, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Glen S Markowitz, Mark A Perazella
Aug 16, 2006·Journal of the American Academy of Dermatology·Margaret D Kottke, Sareeta R S Parker
Nov 4, 2000·Expert Opinion on Investigational Drugs·V F Hoffman, D J Skiest
Mar 30, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Alexander D PortMrinali P Gupta
Jan 5, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Pascal MeierJérôme Rossert
Aug 30, 2008·Antiviral Chemistry & Chemotherapy·Hugh J Field, Erik De Clercq
Oct 5, 2001·Expert Opinion on Pharmacotherapy·M D Khare, M Sharland
Mar 18, 2000·The British Journal of Dermatology·K FifeM Bower
Mar 20, 1999·Current Opinion in Pediatrics·D M Zerr, L M Frenkel
Sep 8, 2011·International Ophthalmology Clinics·Nancy HuynhLucy H Y Young
May 31, 2002·International Journal of STD & AIDS·I G Williams
Jul 11, 2019·Infectious Disorders Drug Targets·Wattana Leowattana
Mar 20, 2019·Current Ophthalmology Reports·Alexander D PortMrinali P Gupta
Dec 9, 2020·Antimicrobial Agents and Chemotherapy·Nichodemus O OnwubikoHeinz Peter Nasheuer
Jan 26, 2021·Frontiers in Chemistry·Elisabetta Groaz, Steven De Jonghe
Apr 30, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hassane IzzedineGilbert Deray
Jan 29, 2000·Seminars in Pediatric Neurology·A T Pavia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.